European Commission - Directorate General for Energy
European Commission - Directorate General for Energy
05/07/2026 | Press release | Distributed by Public on 05/07/2026 08:00
The EU boosts biotech leadership through breakthrough Parkinson’s gene therapy in Poland
A new STEP story highlights how EU support is helping advance an innovative gene therapy for Parkinson's disease at Mazowiecki Szpital Bródnowski in Warsaw.
Parkinson's disease is the second most common neurodegenerative disorder, affecting around 1.2 million people across Europe. Backed by €46.1 million from the European Regional Development Fund, the project is developing a treatment that uses a viral vector to deliver a therapeutical gene directly into specific areas of the brain using advanced neurosurgery and real-time imaging. The therapy aims to slow disease progression, improve motor functions and enhance patients' quality of life.
The project is a concrete example of how STEP is reinforcing Europe's strategic strengths in biotechnology, supporting bold, innovative projects whilst building the continent's long-term competitiveness in critical technologies.
European Commission - Directorate General for Energy published this content on May 07, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on May 07, 2026 at 14:00 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]